T1	HMM 275 287	the efficacy
T2	HMM 377 422	investigate efficacy, safety and tolerability
T3	HMM 902 945	bibrocathol 2Â % showed greater improvement
T4	HMM 1047 1058	the results
T5	HMM 1081 1123	assessments improvement of single symptoms
T6	HMM 1135 1163	discomfort measured by a VAS
T7	HMM 1235 1271	and investigators provided favorable
T8	HMM 1304 1328	bibrocathol over placebo
T9	HMM 1347 1426	were observed with regard to intraocular pressure, visual acuity, or occurrence
